Skip to main content
. 2018 Apr 18;12(6):896–912. doi: 10.1002/1878-0261.12202

Figure 3.

Figure 3

Kaplan–Meier plots of the association between ANP32E expression and outcomes in breast cancer patients. (A–C) High expression of ANP32E correlated with worse OS (A) (n = 1117; P = 0.003), DMFS (B) (n = 1609; P < 0.001), and RFS (C) (n = 2315; P < 0.001) in patients with breast cancer. (D) High expression of ANP32E correlated with worse RFS (n = 255; P = 0.015) in patients with TNBC. Data were obtained from the Kaplan–Meier plotter (http://kmplot.com/analysis/index.php?p=background). DMFS, distant metastasis‐free survival; RFS, relapse‐free survival.